Blockchain Registration Transaction Record

Quantum BioPharma's Unbuzzd Hosts Investor Webinar for $5M Raise

Quantum BioPharma's licensee Unbuzzd Wellness hosts investor webinar for $5M capital raise featuring scientifically proven alcohol metabolism beverage. No dilution to QNTM shareholders.

This development represents a significant advancement in consumer health technology that could transform how people manage alcohol consumption and its aftereffects. The scientifically proven unbuzzd(TM) beverage addresses a widespread global concern affecting millions of people who consume alcohol socially or regularly. Beyond the immediate consumer benefits of reduced hangover symptoms and restored mental clarity, the technology represents a novel approach to alcohol metabolism that could have broader implications for public health and safety. For investors, the non-dilutive financing structure protects existing Quantum BioPharma shareholders while providing capital to accelerate market penetration of a product with substantial commercial potential in the multi-billion dollar wellness and beverage industries.